
1001.3 - Drug eluting bead (DEB): therapy of hepatic metastases in colorectal cancer with Irinotecan (ID: 16007)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
P-286 - Evaluation of a phase III clinical trial comparing transarterial chemoembolisation (TACE) using irinotecan-loaded polyvinyl alcohol microspheres (DEBIRI) vs systemic chemotherapy Folfiri (CT) for the treatment of unresectable metastases to the liver (LM) (ID: 55756)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
1803.3 - Final results of a prospective randomized trial assessing survival at 2 years of DEBIRI vs. FOLFIRI in patients with hepatic metastases from colorectal cancer (ID: 58129)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
1501.3 - Final results of a prospective randomized trial assessing survival at 2 years of DEBIRI vs. FOLFIRI in patients with hepatic metastases from colorectal cancer (ID: 171)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | free |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | free |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | free |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
201.1 - Kolorektale Lebermetastasen Drug Eluting Beads versus FOLFIRI: Randomisierte Studienergebnisse bezüglich Effektivität und Lebensqualität (ID: 122)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| not available | |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | free |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| not available | |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | free |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| not available | |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | free |
| ECIO 2012 | not available |
1603.1 - Lessons learned from more than 350 DEBIRI treatments in a single institution, the oncologist perspective (ID: 47203)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | free |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | free |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | free |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
3102.6 - Systemic therapy is all we need for non-resectable disease (ID: 55379)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
1306.3 - Trans-arterial chemoembolization of liver metastases from colorectal cancer adopting drug-eluting beads loaded with irinotecan compared with FOLFIRI: results at two years of a phase III clinical trial (ID: 56040)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |